about
Personalis Inc is a provider of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, the sale of sequencing and data analysis servi...
Read More
8.78
0.21
(2.45%)
1.2M
XNAS Volume
XNAS 13 Jan, 2026 4:30 PM (EST)
Low Financial Strength
Expensive Valuation
Technically Moderately Bullish
Momentum Trap
These stocks have weak financials and expensive valuation. Buying interest may quickly dissipate. Investors should exercise caution
View Similar
Embed DVM
Personalis Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..